Skin Perfusion Pressure Testing Device Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드:1696369
리서치사:Lucintel
발행일:2025년 03월
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 피부관류압 검사 기기 시장의 미래는 유망하며, 병원 및 외래수술센터(ASC) 시장에 기회가 있습니다. 세계 피부관류압 검사 기기 시장은 2025-2031년 연평균 10.4%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 말초동맥 질환의 유병률 증가, 당뇨병 발생률 증가, 혈관 진단의 지속적인 발전입니다.
Lucintel의 예측에 따르면 제품 유형별로는 초음파가 가장 높은 성장세를 보일 것으로 예측됩니다.
최종 용도별로는 외래 수술센터가 가장 높은 성장이 예상됩니다.
지역별로는 북미가 계속해서 가장 규모가 큰 지역이 될 것으로 예측됩니다.
피부관류압 검사 기기 시장의 전략적 성장 기회
피부관류압(SPP) 검사 기기 시장은 기술 발전, 건강 인식 증가, 환자층의 변화로 인해 풍부한 전략적 성장 기회를 제공합니다. 의료 환경이 계속 진화하는 가운데, 이 분야의 이해관계자들은 다양한 동향을 활용하여 시장 입지를 확대하고 환자 치료를 강화할 수 있습니다. 여기서는 이 시장의 5가지 주요 성장 기회를 소개하고자 합니다.
신흥 시장 진출: 신흥 국가에서는 만성질환의 확산이 확대되고 있으며, 효과적인 진단 툴에 대한 수요가 크게 증가하고 있습니다. 기업은 현지 의료 수요에 맞는 합리적인 가격의 SPP 검사 기기를 제공함으로써 더 많은 고객 기반을 확보하고 브랜드 충성도를 형성함으로써 이들 시장 진출에 전략적으로 집중할 수 있습니다.
스마트 커넥티드 디바이스 개발: 디지털 헬스 플랫폼과 통합된 스마트 커넥티드 SPP 검사 기기에 대한 수요가 증가하고 있습니다. 클라우드 연결 및 모바일 앱과의 호환성과 같은 기능을 통합함으로써 제조업체는 실시간 모니터링 및 데이터 공유를 가능하게 하고, 환자의 참여도를 높이고, 혈관 헬스케어에 대한 적극적인 접근을 촉진할 수 있습니다.
원격의료 프로바이더와의 제휴: 원격의료 플랫폼과의 협력은 SPP 검사를 원격 환자 진료에 통합할 수 있는 독특한 기회를 제공합니다. 원격의료 프로바이더와의 제휴를 통해 기업은 원격 진단 및 모니터링을 용이하게 하고, 편리한 의료 솔루션을 찾는 환자 증가에 대응할 수 있으며, 궁극적으로 장비의 보급과 판매를 촉진할 수 있습니다.
맞춤형 의료에 집중: 의료 산업이 맞춤형 의료로 전환됨에 따라 SPP 기기 제조업체는 개별 환자의 요구에 맞는 맞춤형 솔루션을 개발할 수 있는 기회를 갖게 되었습니다. 맞춤형 기능과 특정 측정 프로토콜을 제공함으로써 기업은 기기의 관련성과 유효성을 높이고 개인화된 혈관 치료의 선두주자로 자리매김할 수 있습니다.
연구개발에 대한 투자: 연구개발에 대한 투자를 늘리면 혁신적인 SPP 검사 기술과 방법을 개발할 수 있습니다. R&D를 우선시함으로써 기업은 장비의 정확성, 사용 편의성, 환자 경험을 개선하고, 시장에서 경쟁 우위를 확보하며, 혈관 진단의 최신 진보를 원하는 의료 서비스 프로바이더의 관심을 끌 수 있습니다.
피부관류압 검사 기기 시장은 이해관계자들이 제품을 강화하고 진입 범위를 확대하기 위해 활용할 수 있는 다양한 전략적 성장 기회를 제공합니다. 신흥 시장, 기술 통합, 개인화 접근 방식에 집중함으로써 기업은 이 역동적인 환경에서 성공할 수 있는 입지를 구축할 수 있습니다.
피부관류압 검사기 시장 활성화 요인 및 과제
피부관류압(SPP) 검사 기기 시장은 성장을 가속하는 다양한 요인과 성장을 저해할 수 있는 과제에 영향을 받습니다. 이러한 요인을 이해하는 것은 진화하는 상황을 효과적으로 헤쳐 나가고자 하는 이해관계자들에게 필수적입니다. 여기서는 시장에 영향을 미치는 5가지 주요 촉진요인과 3가지 과제를 소개합니다.
피부관류압 검사기 시장을 촉진하는 요인은 다음과 같습니다.
만성질환의 유병률 증가: 당뇨병, 말초동맥질환과 같은 만성질환 증가는 피부관류압 검사 기기에 대한 수요를 크게 증가시킬 것입니다. 이러한 질환은 혈관 합병증으로 이어지는 경우가 많기 때문에 의료진은 환자의 혈관 건강을 모니터링하고 관리할 수 있는 정확한 진단 툴을 요구하고 있으며, 이는 시장 성장을 가속하고 있습니다.
기술 발전: 의료 기술의 끊임없는 발전은 SPP 검사 기기의 기술 혁신을 촉진하고 있습니다. 휴대성, 비침습적 측정 기술, 디지털 헬스 솔루션과의 통합 등의 특징이 의료 전문가들에게 더욱 매력적으로 다가와 다양한 임상 현장에서 폭넓게 채택되고 있습니다.
혈관 건강에 대한 인식 증가: 환자와 의료진 사이에서 혈관 건강의 중요성에 대한 인식이 높아지면서 SPP 검사에 대한 수요가 증가하고 있습니다. 조기 진단과 예방을 강조하는 교육적 구상과 캠페인은 정기적인 검진을 장려하며 시장 확대를 더욱 촉진하고 있습니다.
규제 지원 및 승인: 혁신적인 SPP 검사 기기에 대한 우호적인 규제 환경과 간소화된 승인 프로세스는 제조업체의 신제품 출시를 촉진하고 있습니다. 이러한 환경은 기술 혁신을 촉진하고, 의료 서비스 프로바이더에게 임상적으로 효과적인 선택의 폭을 넓혀 궁극적으로 환자 치료를 개선하는 데 도움이 됩니다.
원격의료의 보급: 원격의료의 보급은 SPP 검사 기기에 새로운 기회를 제공합니다. 의료 서비스 프로바이더의 원격 모니터링 사용이 증가함에 따라 SPP 장비를 원격의료 플랫폼에 통합하여 적시에 개입할 수 있게 됨에 따라 보다 혁신적이고 연결성이 높은 장비에 대한 수요가 증가하고 있습니다.
피부관류압 검사기 시장이 해결해야 할 과제는 다음과 같습니다.
고급 기기의 높은 비용: SPP 검사 기기 시장이 직면한 주요 과제 중 하나는 고급 진단 툴와 관련된 높은 비용입니다. 많은 의료 시설, 특히 신흥 시장에서는 이러한 기술을 구매할 여력이 없어 도입이 제한되어 시장 성장을 저해할 수 있습니다.
규제 장애물: 규제 당국의 지원은 확대되고 있지만, 복잡한 규제 상황을 극복하는 것은 여전히 제조업체의 과제입니다. 엄격한 규제 준수 요건을 충족하는 데는 많은 시간과 비용이 소요되므로 제품 출시가 지연되고 중소기업 시장 진입이 제한될 수 있습니다.
경쟁과 시장 포화: SPP 검사 기기 시장은 경쟁이 심화되고 있으며, 많은 기업이 이 분야에 진출하고 있습니다. 이러한 포화 상태는 가격 경쟁과 이익률 하락을 초래하고, 기업이 제공하는 제품을 차별화하고 지속가능한 비즈니스 모델을 유지하는 것을 어렵게 만듭니다.
피부관류압 검사 기기 시장은 성장을 가속하는 주요 요인과 시장 확대에 걸림돌이 되는 과제에 의해 형성되고 있습니다. 이해관계자들은 이러한 역학을 전략적으로 조작하여 진화하는 상황에서 기회를 최적화하고 장애물을 극복하기 위해 노력해야 합니다.
목차
제1장 개요
제2장 세계의 피부관류압 검사 기기 시장 : 시장 역학
서론, 배경, 분류
공급망
업계의 촉진요인과 과제
제3장 시장 동향과 예측 분석(2019-2031년)
거시경제 동향(2019-2024년)과 예측(2025-2031년)
세계의 피부관류압 검사 기기 시장 동향(2019-2024년)과 예측(2025-2031년)
세계의 피부관류압 검사 기기 시장 : 제품 유형별
초음파
레이저 도플러
광전식 용적맥파 기록법
세계의 피부관류압 검사 기기 시장 : 모드별
카트 기반 기기
휴대용 기기
세계의 피부관류압 검사 기기 시장 : 최종 용도별
병원
외래 수술 센터
기타
제4장 지역별 시장 동향과 예측 분석(2019-2031년)
세계의 피부관류압 검사 기기 시장 : 지역별
북미의 피부관류압 검사 기기 시장
유럽의 피부관류압 검사 기기 시장
아시아태평양의 피부관류압 검사 기기 시장
기타 지역의 피부관류압 검사 기기 시장
제5장 경쟁 분석
제품 포트폴리오 분석
운영 통합
Porter's Five Forces 분석
제6장 성장 기회와 전략 분석
성장 기회 분석
세계의 피부관류압 검사 기기 시장의 성장 기회 : 제품 유형별
세계의 피부관류압 검사 기기 시장의 성장 기회 : 모드별
세계의 피부관류압 검사 기기 시장의 성장 기회 : 최종 용도별
세계의 피부관류압 검사 기기 시장의 성장 기회 : 지역별
세계의 피부관류압 검사 기기 시장의 새로운 동향
전략적 분석
신제품 개발
세계의 피부관류압 검사 기기 시장의 생산능력 확대
세계의 피부관류압 검사 기기 시장에서의 기업인수합병(M&A), 합병사업
인증과 라이선싱
제7장 주요 기업의 개요
ADInstruments
CorVascular Diagnostics
Koven Technology
Moor Instruments
Perimed
Promed
Vasamed
KSA
영문 목차
영문목차
The future of the global skin perfusion pressure testing device market looks promising, with opportunities in the hospital and ambulatory surgical center markets. The global skin perfusion pressure testing device market is expected to grow with a CAGR of 10.4% from 2025 to 2031. The major drivers for this market are the increasing incidence of peripheral artery disease, the rising occurrence of diabetes, and ongoing advancements in vascular diagnostics.
Lucintel forecasts that, within the product type category, ultrasound is expected to witness the highest growth.
Within the end-use category, ambulatory surgical center is expected to witness the highest growth.
In terms of regions, North America is expected to witness remain the largest region.
Gain valuable insights for your business decisions with our comprehensive 150+ page report.
Emerging Trends in the Skin Perfusion Pressure Testing Device Market
The skin perfusion pressure (SPP) testing device market is evolving rapidly, influenced by technological advancements and changing healthcare needs. As awareness of vascular health increases and chronic diseases become more prevalent, several key trends are emerging in this sector. Here are five notable trends shaping the market landscape.
Integration of Artificial Intelligence: The incorporation of artificial intelligence into SPP testing devices is transforming diagnostic capabilities. AI algorithms are being developed to analyze SPP data more accurately, helping healthcare professionals identify vascular issues earlier and personalize treatment plans, thereby enhancing patient outcomes.
Miniaturization of Devices: There is a growing trend toward the miniaturization of SPP testing devices, making them more portable and user-friendly. Smaller handheld devices are being designed for ease of use in various settings, including outpatient clinics and home healthcare, increasing accessibility for patients who need regular monitoring.
Telemedicine Integration: With the rise of telemedicine, SPP testing devices are increasingly being integrated into remote healthcare solutions. This trend allows healthcare providers to monitor patients' vascular health from a distance, facilitating timely interventions and reducing the need for in-person visits, thus improving overall care efficiency.
Focus on Non-Invasive Technologies: The market is witnessing a shift toward non-invasive SPP testing methods, driven by patient comfort and preference. New technologies are being developed to provide accurate measurements without the need for invasive procedures, making it easier for patients to undergo regular assessments and leading to higher compliance rates.
Increased Regulatory Approvals: The skin perfusion pressure testing device market is seeing a rise in regulatory approvals for innovative products. This trend is encouraging manufacturers to invest in research and development, leading to more advanced, clinically validated devices entering the market, which in turn boosts consumer confidence and adoption.
The skin perfusion pressure testing device market is on the cusp of significant transformation, driven by technological innovations and changing healthcare demands. As these trends continue to evolve, they promise to enhance diagnostic capabilities and improve patient care outcomes.
Recent Developments in the Skin Perfusion Pressure Testing Device Market
The skin perfusion pressure (SPP) testing device market is experiencing notable advancements driven by innovation and an increasing focus on vascular health. Recent developments in this sector highlight technological enhancements, regulatory changes, and collaborative efforts that aim to improve diagnostics and patient outcomes. Here are five significant recent developments shaping the market.
Launch of Advanced Handheld Devices: Several companies have introduced advanced handheld SPP testing devices that utilize cutting-edge imaging technology. These portable devices offer real-time measurements and are designed for both clinical and home use, enhancing patient accessibility to vital vascular assessments and making monitoring more convenient.
Integration of AI for Enhanced Diagnostics: New SPP devices are increasingly incorporating artificial intelligence algorithms that analyze data to provide more accurate diagnostics. These AI-enhanced tools can identify patterns in blood flow and pressure, enabling healthcare professionals to make quicker, informed decisions regarding patient treatment plans, thereby improving overall care.
Regulatory Approvals for Innovative Technologies: Recent approvals from regulatory bodies like the FDA have paved the way for novel SPP testing devices that utilize non-invasive technologies. This development is encouraging manufacturers to innovate further, leading to a wider range of clinically validated options available to healthcare providers and boosting market growth.
Collaborative Research Initiatives: Collaborative efforts between universities and medical technology companies are yielding promising advancements in SPP testing methodologies. These partnerships aim to enhance device accuracy and reliability, focusing on developing new protocols and technologies that improve the overall effectiveness of vascular assessments.
Expansion of Telehealth Integration: The integration of SPP testing devices into telehealth platforms has gained traction recently. This development enables remote monitoring of patients' vascular health, allowing healthcare providers to conduct assessments without in-person visits. As telehealth continues to grow, this trend supports timely interventions and improves patient adherence to monitoring schedules.
The skin perfusion pressure testing device market is rapidly evolving, marked by innovative technologies and strategic collaborations. These recent developments are set to enhance diagnostic capabilities, improve patient care, and pave the way for a more efficient healthcare landscape.
Strategic Growth Opportunities for Skin Perfusion Pressure Testing Device Market
The skin perfusion pressure (SPP) testing device market presents a wealth of strategic growth opportunities driven by technological advancements, rising health awareness, and changing patient demographics. As the healthcare landscape continues to evolve, stakeholders in this sector can capitalize on various trends to expand their market presence and enhance patient care. Here are five key growth opportunities within the market.
Expansion into Emerging Markets: Emerging economies are experiencing a growing prevalence of chronic diseases, which creates a significant demand for effective diagnostic tools. Companies can strategically focus on entering these markets by offering affordable SPP testing devices tailored to local healthcare needs, thereby capturing a larger customer base and fostering brand loyalty.
Development of Smart, Connected Devices: There is a rising demand for smart, connected SPP testing devices that integrate with digital health platforms. By incorporating features such as cloud connectivity and mobile app compatibility, manufacturers can enable real-time monitoring and data sharing, enhancing patient engagement and fostering a proactive approach to vascular health management.
Partnerships with Telehealth Providers: Collaborating with telehealth platforms offers a unique opportunity to integrate SPP testing into remote patient care. By partnering with telehealth providers, companies can facilitate remote diagnostics and monitoring, catering to the increasing number of patients seeking convenient healthcare solutions, ultimately driving device adoption and sales.
Focus on Personalized Medicine: As the healthcare industry shifts toward personalized medicine, there is an opportunity for SPP device manufacturers to develop tailored solutions that address individual patient needs. By offering customizable features and specific measurement protocols, companies can enhance the relevance and effectiveness of their devices, positioning themselves as leaders in personalized vascular care.
Investment in Research and Development: Increased investment in research and development can yield innovative SPP testing technologies and methodologies. By prioritizing R&D, companies can enhance device accuracy, usability, and patient experience, establishing a competitive edge in the market and attracting interest from healthcare providers looking for the latest advancements in vascular diagnostics.
The skin perfusion pressure testing device market offers a range of strategic growth opportunities that stakeholders can leverage to enhance their offerings and expand their reach. By focusing on emerging markets, technological integration, and personalized approaches, companies can position themselves for success in this dynamic landscape.
Skin Perfusion Pressure Testing Device Market Driver and Challenges
The skin perfusion pressure (SPP) testing device market is influenced by a variety of drivers that promote growth, as well as challenges that may impede progress. Understanding these factors is essential for stakeholders aiming to navigate this evolving landscape effectively. Here are five key drivers and three challenges impacting the market.
The factors responsible for driving the skin perfusion pressure testing device market include:
Increasing Prevalence of Chronic Diseases: The rise in chronic conditions such as diabetes and peripheral artery disease significantly drives the demand for SPP testing devices. As these diseases often lead to vascular complications, healthcare providers are increasingly seeking accurate diagnostic tools to monitor and manage patients' vascular health, thereby boosting market growth.
Technological Advancements: Continuous advancements in medical technology are fostering innovation in SPP testing devices. Features such as portability, non-invasive measurement techniques, and integration with digital health solutions are making these devices more appealing to healthcare professionals, encouraging broader adoption in various clinical settings.
Growing Awareness of Vascular Health: Increased awareness about the importance of vascular health among patients and healthcare providers is driving demand for SPP testing. Educational initiatives and campaigns emphasizing early diagnosis and prevention are encouraging regular screenings, further supporting the market's expansion.
Regulatory Support and Approvals: Favorable regulatory environments and streamlined approval processes for innovative SPP testing devices are encouraging manufacturers to bring new products to market. This supportive landscape fosters innovation, leading to a wider range of clinically validated options for healthcare providers, ultimately enhancing patient care.
Rising Adoption of Telemedicine: The growing adoption of telemedicine is creating new opportunities for SPP testing devices. With healthcare providers increasingly utilizing remote monitoring, integrating SPP devices into telehealth platforms can facilitate timely interventions, thus driving demand for more innovative and connected devices.
Challenges in the skin perfusion pressure testing device market are:
High Costs of Advanced Devices: One of the primary challenges facing the SPP testing device market is the high cost associated with advanced diagnostic tools. Many healthcare facilities, particularly in emerging markets, may struggle to afford these technologies, limiting their adoption and hindering market growth.
Regulatory Hurdles: While regulatory support is growing, navigating the complex regulatory landscape remains a challenge for manufacturers. Meeting stringent compliance requirements can be time-consuming and costly, potentially delaying product launches and limiting market entry for smaller companies.
Competition and Market Saturation: The market for SPP testing devices is becoming increasingly competitive, with numerous players entering the field. This saturation can lead to price wars and reduced profit margins, making it challenging for companies to differentiate their offerings and maintain a sustainable business model.
The skin perfusion pressure testing device market is shaped by key drivers that promote growth alongside challenges that present obstacles to expansion. Stakeholders must strategically navigate these dynamics to optimize opportunities and address the hurdles within this evolving landscape.
List of Skin Perfusion Pressure Testing Device Companies
Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, skin perfusion pressure testing device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the skin perfusion pressure testing device companies profiled in this report include-
ADInstruments
CorVascular Diagnostics
Koven Technology
Moor Instruments
Perimed
Promed
Vasamed
Skin Perfusion Pressure Testing Device by Segment
The study includes a forecast for the global skin perfusion pressure testing device market by product type, mode, end use, and region.
Skin Perfusion Pressure Testing Device Market by Product Type [Analysis by Value from 2019 to 2031]:
Ultrasound
Laser Doppler
Photoplethysmography
Skin Perfusion Pressure Testing Device Market by Mode [Analysis by Value from 2019 to 2031]:
Cart-based Device
Portable Device
Skin Perfusion Pressure Testing Device Market by End Use [Analysis by Value from 2019 to 2031]:
Hospital
Ambulatory Surgical Center
Others
Skin Perfusion Pressure Testing Device Market by Region [Analysis by Value from 2019 to 2031]:
North America
Europe
Asia Pacific
The Rest of the World
Country Wise Outlook for the Skin Perfusion Pressure Testing Device Market
The skin perfusion pressure (SPP) testing device market has seen significant advancements in several key countries, driven by increasing awareness of vascular health and advancements in medical technology. Here is a snapshot of recent developments in the United States, Chinese, German, Indian, and Japanese markets.
United States: The U.S. market is witnessing a surge in SPP device innovation, with companies focusing on integrating advanced imaging technologies and artificial intelligence to enhance diagnostic accuracy. Recent FDA approvals for next-generation devices are expected to broaden market access and improve patient outcomes.
China: In China, the demand for non-invasive diagnostic tools is rising, leading to increased investments in research and development. Local manufacturers are collaborating with international firms to enhance the technological capabilities of SPP devices, catering to a growing healthcare market that emphasizes early disease detection.
Germany: Germany remains a leader in medical technology innovation, with recent developments focusing on portable SPP testing devices. German companies are investing in miniaturization and user-friendly designs, which align with the country's emphasis on efficiency in healthcare delivery and patient-centered care.
India: The Indian market is expanding due to a rising prevalence of diabetes and related complications. Local startups are developing affordable SPP devices tailored for rural healthcare settings, aiming to improve accessibility. Government initiatives promoting medical technology are further supporting this growth.
Japan: The Japanese aging population drives the need for advanced diagnostic tools, including SPP testing devices. Companies are investing in high-precision devices that integrate seamlessly with telemedicine solutions, aligning with Japan's push for enhanced remote healthcare services and patient monitoring.
Features of the Global Skin Perfusion Pressure Testing Device Market
Market Size Estimates: Skin perfusion pressure testing device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Skin perfusion pressure testing device market size by product type, mode, end use, and region in terms of value ($B).
Regional Analysis: Skin perfusion pressure testing device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, modes, end uses, and regions for the skin perfusion pressure testing device market.
Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the skin perfusion pressure testing device market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the skin perfusion pressure testing device market by product type (ultrasound, laser doppler, and photoplethysmography), mode (cart-based device and portable device), end use (hospital, ambulatory surgical center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?
